OpenAI is going to store your information + preferences to give you more customization: OpenAI is rolling out a long-term memory function that will save details about you based on your queries and information you feed into ChatGPT, such as who you are, your interests, your topics of conversation, and how you like to do things to create a more intuitive user experience, reports Wired. The feature, called Memory, builds on the “custom instructions” tool that OpenAI released in July 2023, Wired says.

How will it work? The feature — which allows users to opt out — will remember personal details about you and consider them in future responses. The feature will be available on both the free and paid options.

There are some challenges: You’re right to worry that it could go wrong if a piece of information you didn’t expect to be saved or don’t want others to know about randomly pops up in future conversations. But you can adjust that by using ChatGPT in incognito mode if you want to make a query without inciting the memories, says Axios. And you can also delete memories manually or ask the chatbot to wipe its memory, according to Wired. OpenAI is still ironing out the details, including looking at issues such as whether health and ethnicity data should be stored, to balance personalization with user comfort and security.


Micro-robots could be a game-changer for liver cancer treatment: Canadian researchers have created MRI-guided microscopic robots to revolutionize cancer treatments by more accurately targeting tumors while minimizing any damages to the healthy tissue, Science Focus reports.

At its core, the process involves the use of tiny robots made from magnetic particles. The robots then use magnetic and gravitational forces to navigate through the arteries where the tumor grows.

And AI also lends a helping hand:The main obstacle that scientists needed to overcome was the gravitational force that exceeded the magnetic force in the microrobots, which made their navigation inside the arteries less precise, particularly when tumors were situated higher than the injection site. To overcome this, the researchers started using AI to create an algorithm that optimized the combined effect of gravity and magnetic navigation.

The use of microrobots has shown promising results, but it’s still in its developmental stages. So far there have been experiments on animal models and simulations using human liver data — but the AI models still need further training, especially in the real-time navigation of the microrobots within the liver. Once perfected, this technology could lower the death rate of hepatocellular carcinoma which is responsible for 700k deaths each year globally.